Pasar al contenido principal

NUEVOS COMPLEJOS METALICOS: DIANAS MOLECULARES, Y MODELOS PRECLINICOS DE CANCER

PID2022-137373OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Platinum iodido drugs show potential anti-tumor activity, affecting cancer cell metabolism and inducing ROS and senescence in gastrointestinal cancer cells

  • Melones-Herrero, Jorge
  • Alcalá, Sonia
  • Ruiz-Cañas, Laura
  • Benitez-Buelga, Carlos
  • Batres-Ramos, Sandra
  • Calés, Carmela
  • Lorenzo, Óscar
  • Perona Abellón, Rosario
  • Quiroga, Adoración G.
  • Sainz, Bruno Jr.
  • Sánchez-Pérez, Isabel
Cisplatin-based chemotherapy has associated clinical disadvantages, such as high toxicity and resistance. Thus, the development of new antitumor metallodrugs able to overcome different clinical barriers is a public healthcare priority. Here, we studied the mechanism of action of the isomers trans and cis-[PtI2(isopropylamine)2] (I5 and I6, respectively) against gastrointestinal cancer cells. We demonstrate that I5 and I6 modulate mitochondrial metabolism, decreasing OXPHOS activity and negatively affecting ATP-linked oxygen consumption rate. Consequently, I5 and I6 generated Reactive Oxygen Species (ROS), provoking oxidative damage and eventually the induction of senescence. Thus, herein we propose a loop with three interconnected processes modulated by these iodido agents: (i) mitochondrial dysfunction and metabolic disruptions; (ii) ROS generation and oxidative damage; and (iii) cellular senescence. Functionally, I5 reduces cancer cell clonogenicity and tumor growth in a pancreatic xenograft model without systemic toxicity, highlighting a potential anticancer complex that warrants additional pre-clinical studies., This research was funded by PID2019-106220RB100, RTC2019-007227-1 granted by MICIU/ AEI / 10.13039/501100011033, and PID2022-137373OB-I00 granted by MICIU/ AEI / 10.13039/501100011033 / FEDER, UE. This study was supported by ISCIII FIS grants PI20/0335 (RP) and PI21/01110 (BSJ), co-financed through Fondo Europeo de Desarrollo Regional (FEDER) ’Una manera de hacer Europa’. JMH was supported by a grant FPI-UAM 2021 from Universidad Autónoma de Madrid (Molecular BioSciences PhD program). We thank Gonzalo Vílchez and Sofia Figueiras for their contribution to this work via Comunidad de Madrid grants PEJ-2020-AI/BMD-18538; PEJ-2021-TL/BMD-22441., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 S Protein Reduces Cytoprotective Defenses and Promotes Human Endothelial Cell Senescence

  • Villacampa, Alicia
  • Shamoon, Licia
  • Valencia, Inés
  • Morales, Cristina
  • Figueiras, Sofía
  • de la Cuesta, Fernando
  • Sánchez-Niño, Dolores
  • Díaz-Araya, Guillermo
  • Sánchez-Pérez, Isabel
  • Lorenzo, Óscar
  • Sánchez-Ferrer, Carlos Félix
  • Peiró, Concepción
Premature vascular aging and endothelial cell senescence are major risk factors for cardiovascular diseases and atherothrombotic disturbances, which are main complications of both acute and long COVID-19. The S protein of SARS-CoV2, which acts as the receptor binding protein for the viral infection, is able to induce endothelial cells inflammation and it has been found as an isolated element in the circulation and in human tissues reservoirs months after infection. Here, we investigated whether the S protein is able to directly induce endothelial cell senescence and deciphered some of the mechanisms involved. In primary cultures of human umbilical vein endothelial cells (HUVEC), SARS-CoV-2 S protein enhanced in a concentration-dependent manner the cellular content of senescence and DNA damage response markers (senescence-associated-β galactosidase, γH2AX), as well as growth-arrest effectors (p53, p21, p16). In parallel, the S protein reduced the availability of cytoprotective proteins, such as the anti-aging protein klotho, Nrf2 or heme oxygenase-1, and caused functional harm by impairing ex vivo endothelial-dependent vasorelaxation in murine microvessels. These effects were prevented by the pharmacological inhibition of the NLRP3 inflammasome with MCC950. Furthermore, the supplementation with either recombinant klotho or angiotensin-(1-7), equally protected against the pro-senescence, pro-inflammatory and pro-oxidant action of the S protein. Globally, this study proposes novel mechanisms of disease in the context of COVID-19 and its vascular sequelae and provides pharmacological clues in order to prevent such complications., This work was supported by grants from REACT-EU-Comunidad de Madrid and the European Regional Development Fund (SPACE2-CV-COVID-CM) to CP and OL, Plan Nacional I+D (PID2020-115590RB-100/AEI/https://doi.org/10.13039/501100011033) to CP and CFSF. Fondo de Investigación Sanitaria-FIS Carlos III (PI20/00923) to OL. Plan Nacional I+D (PID2022-137373OB-I00 granted by MICIU/AEI/10.13039/ 501100011033 / FEDER, UE to ISP. Plan Nacional I+D (PID2021-126274OB-I00) to FC. L.S. is the recipient of FPI Universidad Autónoma de Madrid (SFPI / 2020-00053). IV is the recipient of a Sara Borrell postdoctoral grant (CD22/00101). SF was supported by Comunidad de Madrid grants PEJ-2021-TL/BMD-22441., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Trans-[Pt(amine)Cl2(PPh3)] Complexes Target Mitochondria and Endoplasmic Reticulum in Gastric Cancer Cells

  • Melones-Herrero, Jorge
  • Delgado-Aliseda, Patricia
  • Figueiras, Sofía
  • Velázquez-Gutiérrez, Javier
  • Gómez Quiroga, Adoración
  • Calés, Carmela
  • Sánchez-Pérez, Isabel
Gastric cancer prognosis is still notably poor despite efforts made to improve diagnosis and treatment of the disease. Chemotherapy based on platinum agents is generally used, regardless of the fact that drug toxicity leads to limited clinical efficacy. In order to overcome these problems, our group has been working on the synthesis and study of trans platinum (II) complexes. Here, we explore the potential use of two phosphine-based agents with the general formula trans-[Pt(amine)Cl2(PPh3)], called P1 and P2 (with dimethylamine or isopropylamine, respectively). A cytotoxicity analysis showed that P1 and especially P2 decrease cell viability. Specifically, P2 exhibits higher activity than cisplatin in gastric cancer cells while its toxicity in healthy cells is slightly lower. Both complexes generate Reactive Oxygen Species, produce DNA damage and mitochondrial membrane depolarization, and finally lead to induced apoptosis. Thus, an intrinsic apoptotic pathway emerges as the main type of cell death through the activation of BAX/BAK and BIM and the degradation of MCL1. Additionally, we demonstrate here that P2 produces endoplasmic reticulum stress and activates the Unfolded Protein Response, which also relates to the impairment observed in autophagy markers such as p62 and LC3. Although further studies in other biological models are needed, these results report the biomolecular mechanism of action of these Pt(II)-phosphine prototypes, thus highlighting their potential as novel and effective therapies., This research was funded by PID2019-106220RB100 granted by MICIU/AEI/10.13039/501100011033 and PID2022-137373OB-I00 granted by MICIU/AEI/10.13039/501100011033/FEDER, UE. J.M.-H. was supported by the grant FPI-UAM 2021 from Universidad Autónoma de Madrid (Molecular BioSciences PhD programme). P.D.-A. was supported by the Comunidad de Madrid grant PEJ-2023-AI/SAL-GL-28061. S.F. was supported by the Comunidad de Madrid grant PEJ-2021-TL/BMD-22441. J.V.-G. was supported by Programa Investigo, in the frame of Recovery Plan, transformation and Resilience–NextGeneration EU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A select thiosemicarbazone copper(II) complex induces apoptosis in gastric cancer and targets cancer stem cells reducing pluripotency markers

  • Fabra, David
  • Melones-Herrero, Jorge
  • Velázquez-Gutiérrez, Javier
  • Matesanz, Ana I.
  • Aliseda, Patricia D.
  • Figueiras, Sofía
  • Aguilar-Rico, Francisco
  • Calés, Carmela
  • Sánchez-Pérez, Isabel
  • Quiroga, Adoración G.
Copper(II)-based complexes are promising candidates as anti-cancer agents due to their ability to target cancer cells. Here we describe the synthesis and characterization of two copper(II) thiosemicarbazone complexes with the ligands 4-(dimethylamino)benzaldehyde N4-methylthiosemicarbazone (HL1) and 4-(dimethylamino)benzaldehyde N4-(4-(dimethylamino)phenylthiosemicarbazone (HL2) and general formula [Cu(L)2]. The complexes show stability in aqueous solution with 1 % of DMSO that allows to stablish its solution profile in biological buffers. Compound [Cu(L1)₂] lipophilicity was lower than [Cu(L2)₂], however, its solubility in biological buffer was not only better but also its DLS and ζ-potential data. In vitro studies demonstrate a higher cytotoxic effect of [Cu(L1)₂] on gastric cancer cells. The proposed mechanism of action consists in the generation of free radicals that induce DNA lesions, oxidative stress and ultimately autophagy deregulation and apoptosis. Additionally, [Cu(L1)₂] is equally active on gastric cancer stem cells and tumor cells resistant to cisplatin. More importantly, stem cells treated with [Cu(L1)₂] show a downregulation of pluripotency markers such as TWIST, NANOG and OCT4. Overall, our results with [Cu(L1)₂] prompt a significant advancement in the development of rational-designed pharmaceuticals for combating cancer., This research was funded by PID2019-106220RB100 granted by MICIU/AEI/10.13039/501100011033, and PID2022-137373OB-I00 granted by MICIU/AEI/10.13039/501100011033/FEDER, UE. JVG was supported by Programa Investigo, in the frame of Recovery Plan, transformation and Resilience– NextGeneration EU. JMH was supported by a grant FPI-UAM 2021 from Universidad Autónoma de Madrid (Molecular BioSciences PhD programme). PDA was supported by Comunidad de Madrid grant PEJ-2023-AI/SAL-GL-28061. SFV was supported by Comunidad de Madrid grants PEJ-2021-TL/BMD-22441. FAR was supported by Comunidad de Madrid grants PIPF-2022/SAL-GL-25290, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antiproliferative activity in breast cancer cells of PtL2: A steroid-thiosemicarbazone platinum(II) complex

  • Melones-Herrero, Jorge
  • Aguilar-Rico, Francisco
  • Matesanz, Ana I.
  • Calés, Carmela
  • Sánchez-Pérez, Isabel
  • Quiroga, Adoración G.
Breast cancer remains one of the most diagnosed cancers in women worldwide. Metallodrugs such as cisplatin are used in advanced stages and hormone independent tumors. We hereby report the synthesis and characterization of a new benzaldehyde thiosemicarbazone functionalized with an estradiol derivative, LH, and two metal complexes, PdCl2(LH) and PtL2. Both complexes were studied in solution showing enough stability to further perform antitumoral activity studies. The Pd(II) complex was discarded for its poor performance while PtL₂ exhibited similar cytotoxic activity to cisplatin (CDDP) in estrogen receptor (+) and triple-negative breast cancer cells. Moreover, PtL₂ demonstrated reduced toxicity in healthy cell lines. It induced cell cycle arrest at the G0/G1 phase, distinguishing its mechanism of action from CDDP, which predominantly blocks cells in the S phase. Additionally, PtL₂ displayed a balanced intracellular distribution between the nucleus and cytoplasm, independent of estrogen receptor status. Further analysis revealed that PtL₂ dysregulated antioxidant enzyme expression, potentially disrupting redox homeostasis. These findings highlight PtL₂’s potential as a promising alternative to conventional platinum-based therapies, warranting further investigation into its molecular mechanisms and therapeutic applications., This research was funded by PID2019-106220RB100 granted by MICIU/ AEI / 10.13039/501100011033, and PID2022-137373OB-I00 granted by MICIU/ AEI / 10.13039/501100011033 / FEDER, UE. JMH was supported by a grant FPI-UAM 2021 from Universidad Autónoma de Madrid (Molecular BioSciences PhD programme). FAR was supported by Comunidad de Madrid grants PIPF-2022/SAL-GL-25290., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural features and antibacterial activity of Ni(II) thiosemicarbazones in a zirconium metal-organic framework composite

  • Loukopoulos, Edward
  • Fabra, David
  • Melones-Herrero, Jorge
  • Matesanz, Ana I
  • Viciana, Carmen
  • Platero-Prats, Ana E.
  • Sánchez-Pérez, Isabel
  • Quiroga, Adoracion G
Metal-Organic Frameworks for Biological Applications (BioMOFs) are materials that incorporate therapeutically active ligands into the framework that offer an alternative strategy which combines the structural advantages of MOFs with enhanced functionality for pharmacological properties. The tunable interactions between metal nodes and organic linkers in MOFs favor gradual degradation and/or release of bioactive species. In this work we present the synthesis and detailed characterization of a composite incorporating a Nickel(II) thiosemicarbazone complex and MOF-808. The composite releases Ni(II) species in a controlled manner over 24 h, as demonstrated by UV and NMR. This phenomenon has been applied to inhibit bacterial growth. This research will encourage further exploration into the rational design of new thiosemicarbazones/MOFs materials., This research was funded by Spanish MCIN/AEI/FEDER (10.13039/501100011033) PID2022-137373OB-I00. APP thanks to CNS2022-135261, RYC2018-024328-I and PID2021-123839OB-I00 funded by MICIU/AEI/10.13039/501100011033 and the NextGeneration EU/PRTRTEC-2024/TEC-308 funded by Regional Government of Madrid. E. L. acknowledges financial support from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 101034324 and the “María de Maeztu” Programme for Units of Excellence in R&D (CEX2023-001316-M). JMH was supported by a grant FPI-UAM 2021 from Universidad Autónoma de Madrid (Molecular BioSciences PhD programme). We thank Javier Montero for his contribution to early testing., Peer reviewed